Company: BDRX
Filing Date: 2025-11-17
Form Type: F-1
Source: 0001214659-25-016821
Chunk: 25

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: F-1
Chunk 25
---
 value of our Depositary Shares for any return on their investment.

We have never paid cash dividends
on our Depositary Shares and do not plan to pay any cash dividends in the near future. We currently intend to retain all of our future
earnings, if any, to finance the operation, development and growth of our business. Furthermore, any future debt agreements may also preclude
us from paying or place restrictions on our ability to pay dividends. As a result, capital appreciation, if any, of our Depositary Shares
will be your sole source of gain with respect to your investment for the foreseeable future.

Because our management will have broad discretion and flexibility in how the net proceeds from this offering are used, our management may use the net proceeds in ways with which you disagree or which may not prove effective.

We currently intend to use
the net proceeds from this offering as discussed under “Use of Proceeds” in this prospectus. We have not allocated
specific amounts of the net proceeds from this offering for any of the foregoing purposes. Accordingly, our management will have significant
discretion and flexibility in applying the net proceeds of this offering. You will be relying on the judgment of our management with regard
to the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the net
proceeds are being used appropriately. It is possible that the net proceeds will be invested in a way that does not yield a favorable,
or any, return for us. The failure of our management to use such funds effectively could have a material adverse effect on our business,
financial condition, operating results and cash flow.

The liquidity and trading volume of our Depositary Shares could be low.

The liquidity and trading
volume of our Depositary Shares has at times been low in the past and could again be low in the future. If the liquidity and trading volume
of our Depositary Shares is low, this could adversely impact the trading price of our shares, our ability to issue stock and our stockholders’
ability to obtain liquidity in their shares.

This is a best efforts offering, no minimum amount of securities is required to be sold, and we may not raise the amount of capital we believe is required for our business plans, including our near-term business plans.

The Placement Agent has agreed to use its
reasonable best efforts to solicit offers to purchase the securities in this offering. The Placement Agent has no obligation to buy any
of the securities from us or to arrange for the purchase